AMPATH launches its Pathology Laboratory in Mumbai

MUMBAI, India, Nov. 26, 2021 /PRNewswire/ — After setting up consecutive successful labs across various locations, AMPATH (American Institute of Pathology & Laboratory Sciences Pvt Ltd) is all set to set afloat in Mumbai, with state-of-the-art facilities and an efficiently skilled team that would offer patients superior, progressive, accurate and reliable sets.

AMPATH offers a wide range of best-in-class diagnostic sets with over 2450 tests from Clinical Biochemistry, Hematology, Clinical Pathology, Microbiology, Immuno Phenotyping, Serology, Immunology, Histopathology, Cytology, Immunohistochemistry, Molecular diagnosis, NGS, Cytogenesis and much more. These sets help in diagnosis and detection of various diseases affecting different organs and parts of the body that can be extremely vital.

The lab has collaborated with UPMC, one of the top ranked hospitals in the United States, which allows them to work with the world’s leading clinicians to help them ensure customers comprehensive sets that mirror accuracyn and accuracy in every test conducted. AMPATH is the only Indian lab that has the only privilege of collaborating with such an esteemed and acclaimed global medical organization. It has seamlessly managed to keep par with international standards in testing procedures and quality protocols that have been developed under the expert guidance of UPMC.

Dr. Jagprag Singh Gujral, Group CEO, South Asia, CTSI, commented, “We are extremely delighted and pleased to announce the set afloat of our newest lab in Mumbai. Working in tandem with achieving our vision, we are proud to have expanded our presence in one of the leading markets and will now be able to serve the population of Mumbai with its automated and best-in-class, progressive test profile and quality standards. CTSI, by its network of 16 Cancer Hospitals in South Asia, American Oncology Institute (AOI), Multispecialty-Citizens Specialty Hospital and chain of specialty diagnostic laboratories- AMPATH is at the spotlight of providing outcome focused healthcare sets in South Asia. We strive to provide top-notch sets, innovation and quality pushed results in all our endeavors.”

Dr. Vijay Kumar Vemuri, Group Chief Operating Officer, CTSI, said, “It is with utmost pride that we proportion the announcement of the set afloat of our newest lab in Mumbai. consist with AMPATH’s standards, the lab has automated streamlined processes, qualified and talented clinical experts with access to top-class technological equipment and are relentlessly trained to follow procedures that deliver accuracy in every single test.”

Commenting on the set afloat, Dr. Mukesh Agrawal, Lab Director, said, “We are elated on opening a new lab and expanding our presence in the city of Mumbai where we will be offering various diagnostic sets inclusive of microbiology and molecular testing. With high-tech equipment and a team of skilled professionals, we hope to continually and efficiently service our customers with quality and enhanced healthcare sets.”

AMPATH strive closer to its mission of providing world class service and accurate diagnosis has multiple projects underway to aid its expansion across various geographical locations in India. They aim to meet India’s regularly changing dynamics in the healthcare sector with consistency and efficiency.

Currently, AMPATH has 10 existing Labs, 1700+ clients & two upcoming Labs in India, with approx. 2450 tests and profiles conducted. It delivers a spectrum of progressive diagnostic sets emphasizing quality, ethics, innovation, and best-in-class laboratory practices with reliable performance.


AMPATH (American Institute of Pathology and Laboratory Sciences) represents a clutter-breaking new paradigm for comprehensive Pathology sets in India. Over the years, AMPATH has positioned itself as a brand with consummate repute for trust, rapidity and pin-point accuracy.

AMPATH is the only reference laboratory in India in collaboration with UPMC to ensure every single test conducted is precise and accurate and at par with international standards.

With approx. 2450 tests and profiles conducted, AMPATH delivers an complete spectrum of progressive diagnostic sets emphasizing on quality, ethics, innovation, and best-in-class laboratory practices. Cancer diagnosis, neurological disorders, infectious diseases, genetic abnormalities and more, the clinical coverage wielded by AMPATH in India is at par with the best in the world. The indomitable spirit to unprotected to steadfast excellence at every step is underlined by AMPATH’s apparent technological superiority and richer skills backed by a warm and patient-centric approach.


This Press Release has not been vetted or endorsed by The Eastern Herald’s editorial staff.

Follow us on:

Eastern Herald on Google News

Click: See details

Leave a Reply